Dear Doctors: I have Type 2 diabetes, and in the last year, I have had a problem with excessive itching of my feet. A nerve study showed I had good nerves to my feet, but there might be problems with ...

The peripheral nerve is often the most affected in diabetic neuropathy. Also known as peripheral neuropathy, it refers to any nerve damage outside of the brain and spinal cord. It typically affects ...

Diabetic neuropathy of the feet is a common complication of diabetes. It can cause pain or feelings of numbness and tingling in the feet. You can’t reverse it, but you can prevent it. Diabetic ...

Peripheral neuropathy is a condition that often causes foot numbness, pain, and can lead to leg weakness and balance issues. If you’re experiencing these symptoms, you don’t have to suffer anymore. Dr ...

Pete Doherty has spoken about his health in a new interview. (Getty Images) Pete Doherty, former frontman of The Libertines who later pursued a solo career under the name Babyshambles, has revealed it ...

BETHESDA, Md., Nov. 1, 2019 /PRNewswire/ -- The American Podiatric Medical Association announced today a new public education campaign, Don't Lose Your Nerve to Diabetes. The campaign will educate the ...

PHILADELPHIA -- People who are obese often develop Type 2 diabetes, and ne side effect of that is nerve damage in the hands, feet, and legs. But there's been very little attention to this neuropathy, ...

Peripheral neuropathy is more than tingling feet—left untreated it can progress to chronic pain, falls, infections and even amputations, but early care may protect mobility and independence.

(Reuters Health) - Diabetics with nerve damage are more likely to have an uneven stride and struggle to maintain their balance even when walking on flat ground, a small study finds. So-called ...

Neuropathic ulcers are a common complication in people with nerve damage, particularly those with diabetes or spinal cord injuries. Neuropathic ulcers can be challenging to treat, leading to ...

A large population-based study found that adults with type 2 diabetes (T2D) who start treatment with sodium–glucose cotransporter-2 (SGLT-2) inhibitors have a slightly lower risk of developing ...